Cargando…

HIV therapy in an ageing population — the challenge of polypharmacy

Detalles Bibliográficos
Autor principal:	Back, DJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112839/ http://dx.doi.org/10.1186/1758-2652-13-S4-O26

Ejemplares similares

The challenge of HIV treatment in an era of polypharmacy
por: Back, David, et al.
Publicado: (2020)

Vaccination of HIV positive children... a genuine challenge
por: Vlad, Delia Adelina, et al.
Publicado: (2013)

HIV-TB the deadly duo, the biggest health challenge in Fiji
por: Muller, Santhakumari, et al.
Publicado: (2012)

The challenges of managing antiretroviral treatment in children perinatally infected with HIV in Romania
por: Cibea, Alina, et al.
Publicado: (2014)

Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus
por: Dragovic, Gordana, et al.
Publicado: (2014)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

S2.2c Talaromycosis in HIV-negative patients: challenges and counter-measures
por: Cao, Cunwei
Publicado: (2022)

Shaping humoral responses against mini-libraries of HIV env antigens via lipid nanoparticle vaccine delivery
por: Hanson, MC, et al.
Publicado: (2012)

The Next Therapeutic Challenge in HIV: Polypharmacy
por: Edelman, E. Jennifer, et al.
Publicado: (2013)

International perspectives on adherence and resistance to HIV antiretroviral therapy
por: Bangsberg, D
Publicado: (2010)

Mitochondrial ageing and antiretroviral therapy exposure
por: Payne, BAI, et al.
Publicado: (2010)

HIV replication and evolution in patients on highly active antiretroviral therapy
por: Siliciano, Robert F
Publicado: (2006)

Abstracts of the 8th HIV Persistence during Therapy Workshop
Publicado: (2017)

The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers
por: Ashby, J, et al.
Publicado: (2010)

Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs
por: Andersen-Nissen, E, et al.
Publicado: (2012)

Major issues and their solutions in the management of HIV and TB — from the laboratory to the patient and population
por: Schechter, M
Publicado: (2010)

MDR1 gene polymorphisms and HIV therapeutic response in South Indian population
por: Lingaiah, Shruthi, et al.
Publicado: (2014)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Treatment planning for Interstitial Photodynamic Therapy for head and neck cancer
por: van Veen, RLP, et al.
Publicado: (2010)

The chemistry and biology of KP-1461, a selective nucleoside mutagen for HIV therapy
por: Harris, Kevin, et al.
Publicado: (2006)

HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
por: Molagic, Violeta, et al.
Publicado: (2013)

71. Increasing Trends in Multimorbidity and Polypharmacy Over a 5-Year Period in People Living with HIV in the United States
por: Paudel, Misti, et al.
Publicado: (2021)

Contemporary Ventilation Strategies And Adjunctive Therapies For Acute Respiratory Distress Syndrome (Ards)
por: Duan, EH, et al.
Publicado: (2015)

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children
por: Zhang, C, et al.
Publicado: (2010)

Inflammatory angiogenesis as a target for prevention and therapy: Kaposi's sarcoma and HIV tat as models
por: Albini, Adriana, et al.
Publicado: (2006)

OA031-03. Increased regulatory T cell frequency and HIV-1 specific suppression after therapeutic vaccination of HIV-infected patients on antiretroviral therapy
por: Macatangay, BC, et al.
Publicado: (2009)

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results
por: Slamon, DJ
Publicado: (2000)

Factors associated with loss to follow up after entry into care of HIV infected children ineligible for antiretroviral therapy: data from an HIV cohort study in India
por: Naik, Praveen Kumar, et al.
Publicado: (2014)

Monoclonal antibodies and small-molecules as distinct subclasses of CCR5-targeted therapies for HIV-1
por: Olson, William C
Publicado: (2006)

Metabolic syndrome, insulin resistance and the risk of cardiovascular disease in HIV patients undergoing antiretroviral therapy
por: Tilişcan, Cătălin, et al.
Publicado: (2013)

Correlation between inflammatory biomarkers and metabolic disorders in HIV infected patients undergoing antiretroviral therapy
por: Mihăilescu, Raluca, et al.
Publicado: (2013)

Food allergy population thresholds: an evaluation of the dosing scheme and number of oral food challenges on the accuracy of threshold dose studies
por: Klein Entink, Rinke, et al.
Publicado: (2015)

History of HAART – the true story of how effective multi-drug therapy was developed for treatment of HIV disease
por: Delaney, Martin
Publicado: (2006)

Leptin dysfunction and the risk of dyslipidemia and metabolic syndrome in Romanian HIV-infected patients undergoing antiretroviral therapy
por: Tilişcan, Cătălin, et al.
Publicado: (2014)

Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution in vivo
por: Pasternak, Alexander, et al.
Publicado: (2013)

Identifying specific social challenges of rare diseases: current challenges and issues
por: Dan, Dorica, et al.
Publicado: (2014)

Challenges in agrochemicals design
por: Schleifer, KJ
Publicado: (2013)

Challenges in malaria modeling
por: McKenzie, F Ellis
Publicado: (2014)

Challenges in surveillance and response
por: Slutsker, Laurence
Publicado: (2012)

Attacking latent HIV: towards eradication of HIV infection
por: Margolis, DM
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_qs9k2jq1dj3c8itthfnuvgtohq